|
DE19906744A1
(de)
*
|
1999-02-18 |
2000-08-24 |
Martin Roecken |
Verfahren zur Herstellung antitumoraler Th1-Zellen
|
|
EP1171612A2
(en)
*
|
1999-04-09 |
2002-01-16 |
Biomira, Inc. |
Telomerase-specific cancer vaccine
|
|
DE19917195B4
(de)
|
1999-04-16 |
2006-09-28 |
Immatics Biotechnologies Gmbh |
Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor
|
|
DE60030450T2
(de)
*
|
1999-09-08 |
2007-08-30 |
Transgene S.A. |
Von MUC-1 abgeleitete Peptide
|
|
GB9921337D0
(en)
*
|
1999-09-09 |
1999-11-10 |
Axis Genetics Plc |
Modified plant viruses
|
|
GB0007150D0
(en)
*
|
2000-03-24 |
2000-05-17 |
Lamellar Therapeutics Limited |
Immunotherapeutic methods and compositions
|
|
US8198400B2
(en)
|
2001-03-27 |
2012-06-12 |
Oncothyreon, Inc. |
Vaccine for modulating between T1 and T2 immune responses
|
|
WO2003077865A2
(en)
|
2002-03-15 |
2003-09-25 |
Baxter International Inc. |
Methods and compositions for directing cells to target organs
|
|
WO2003089574A2
(en)
*
|
2002-04-15 |
2003-10-30 |
Biomira, Inc. |
Synthetic glyco-lipo-peptides as vaccines
|
|
EP1537143A2
(en)
*
|
2002-09-05 |
2005-06-08 |
Cell Center Cologne GmbH |
Immunogenic muc1 glycopeptides
|
|
EP1554575A2
(en)
*
|
2002-10-10 |
2005-07-20 |
The U.S. Government represented by The Department of Veterans Affairs |
Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
|
|
US20050045205A1
(en)
*
|
2003-08-29 |
2005-03-03 |
Stach Steven R. |
Apparatus and method for cleaning printed circuit boards
|
|
GB0322448D0
(en)
|
2003-09-25 |
2003-10-29 |
Lamellar Therapeutics Ltd |
Using lamellar bodies to modify linear biological macro molecules
|
|
CA2547635C
(en)
|
2003-12-12 |
2016-02-09 |
Jeffrey Schlom |
A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
|
|
TW201204410A
(en)
|
2004-04-01 |
2012-02-01 |
Oncothyreon Inc |
Mucinous glycoprotein (MUC-1) vaccine
|
|
WO2006050116A1
(en)
*
|
2004-11-02 |
2006-05-11 |
Biomedical Research Models, Inc. |
Methods of cancer treatment/prevention using cancer cell-specific surface antigens
|
|
EP1896051B1
(en)
*
|
2005-06-28 |
2014-10-15 |
Oncothyreon Inc. |
Method of treating patients with a mucinous glycoprotein (muc-1) vaccine
|
|
EP1989326A4
(en)
|
2006-01-17 |
2009-09-30 |
Health Research Inc |
BIO-HETERODUPLEX TRACKING TEST
|
|
RU2377994C1
(ru)
*
|
2008-05-21 |
2010-01-10 |
Леонид Валентинович Загребин |
Способ иммунореабилитации онкозаболеваний
|
|
US20120039984A1
(en)
|
2008-07-03 |
2012-02-16 |
University Of Georgia Research Foundation, Inc. |
Glycopeptide and uses thereof
|
|
WO2010030505A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Austin American Technology Corporation |
Cleaning and testing ionic cleanliness of electronic assemblies
|
|
EP2574170A4
(en)
|
2010-05-10 |
2013-11-20 |
Ascend Biopharmaceuticals Pty Ltd |
IMMUNOSTIMULATORY AND VACCINE COMPOSITIONS
|
|
AU2012222188A1
(en)
|
2011-02-24 |
2013-08-15 |
Oncothyreon Inc. |
MUC1 based glycolipopeptide vaccine with adjuvant
|
|
JP6523685B2
(ja)
|
2012-01-03 |
2019-06-05 |
アメリカ合衆国 |
Ｍｕｃ１腫瘍抗原のネイティブ及びアゴニストｃｔｌエピトープ
|
|
EP2996708A1
(en)
|
2013-05-14 |
2016-03-23 |
Merck Patent GmbH |
Method of treating lung cancer by vaccination with muc-1 lipopeptide
|
|
WO2015058831A1
(en)
|
2013-10-25 |
2015-04-30 |
Merck Patent Gmbh |
Elevated biomarker expression in lung cancer patients responding to treatment with muc-1 lipopeptide vaccines
|
|
JP7250677B2
(ja)
|
2016-12-22 |
2023-04-03 |
キュー バイオファーマ， インコーポレイテッド |
Ｔ細胞調節多量体ポリペプチド及びその使用方法
|
|
US11851471B2
(en)
|
2017-01-09 |
2023-12-26 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
KR102619015B1
(ko)
|
2017-03-15 |
2023-12-28 |
큐 바이오파마, 인크. |
면역 반응을 조절하는 방법
|
|
GB201812647D0
(en)
|
2018-08-03 |
2018-09-19 |
Chancellor Masters And Scholars Of The Univ Of Oxford |
Viral vectors and methods for the prevention or treatment of cancer
|
|
JP2022536581A
(ja)
*
|
2019-06-19 |
2022-08-18 |
キュー バイオファーマ， インコーポレイテッド |
多量体ｔ細胞調節性ポリペプチド及びその使用方法
|
|
CA3169949A1
(en)
|
2020-05-12 |
2021-11-18 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
JP2023541366A
(ja)
|
2020-09-09 |
2023-10-02 |
キュー バイオファーマ， インコーポレイテッド |
１型真性糖尿病（ｔ１ｄ）を治療するためのｍｈｃクラスｉｉ ｔ細胞調節多量体ポリペプチド及びその使用方法
|